+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Risk factors for invasive fungal infections in liver transplant recipients receiving tacrolimus as primary immunosuppression



Risk factors for invasive fungal infections in liver transplant recipients receiving tacrolimus as primary immunosuppression



Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36(0): 242




(PDF emailed within 1 workday: $29.90)

Accession: 033251322

Download citation: RISBibTeXText


Related references

Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent. Clinical Infectious Diseases 24(2): 179-184, 1997

Risk factors for development of infectious complications in adult liver transplant recipients receiving tacrolimus immunosuppression. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 34(0): 9, 1994

Predictors and outcome of early- versus late-onset major bacterial infections in liver transplant recipients receiving tacrolimus (FK506) as primary immunosuppression. European Journal of Clinical Microbiology and Infectious Diseases 16(11): 821-826, 1998

Predictors and outcome of early- versus late-onset major bacterial infections in liver transplant recipients receiving tacrolimus (FK506) as primary immunosuppression. European Journal of Clinical Microbiology & Infectious Diseases 16(11): 821-826, 1997

Risk factors for invasive fungal infections in liver transplant recipients. Chinese Medical Journal 125(2): 400, 2012

Risk factors for early invasive fungal infections in paediatric liver transplant recipients. Mycoses 2018, 2018

Invasive Fungal Infections in Renal Transplant Recipients: Epidemiology and Risk Factors. Mycopathologia 180(1-2): 43-50, 2016

Use of basiliximab induction in low-immunological risk renal transplant recipients receiving tacrolimus-based immunosuppression. Transplantation Proceedings 41(6): 2337-2338, 2010

Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients. Transplantation 87(3): 424-435, 2009

Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients. Mycopathologia 182(5-6): 495-504, 2017

Invasive fungal infections in pediatric heart transplant recipients: incidence, risk factors, and outcomes. Pediatric Transplantation 15(5): 465-469, 2012

Risk factors for the development of invasive fungal infections in allogeneic blood and marrow transplant recipients. Transplant Infectious Disease 4(1): 3-9, 2002

Bloodstream infections in liver transplant recipients receiving tacrolimus. Clinical Transplantation 11(4): 275-281, 1997

Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study. American Journal of Transplantation 6(2): 386-391, 2006

Risk factors for systemic fungal infections in liver transplant recipients. European Journal of Clinical Microbiology & Infectious Diseases 14(5): 375-382, 1995